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Étude de l'influence de différents HPLC-Phasen sur la séparation 
des peptides de synthèse.  
Untersuchung des Einfluss verschiedener HPLC-Phasen auf der 
trennung von synthetischen Peptiden.  
 
Objectif 
Différentes phases HPLC et UPLC sont testées dans l’optique de généraliser l’approche de la 
séparation des peptides synthétiques. 
Résultats 
Concernant le peptide de 20 acides aminés ± 2 glycines, les meilleures résultats de séparations 
sont obtenus avec l’UPLC { pH 3 avec une solution de perchorate 100 mM, mais la phase HPLC 
Waters HILC permet pour une séparation moins performante (Rs 1.06 contre 1.60) de réduire le 
temps d’analyse d’un facteur 1.5. 
Pour les diastéréomères, petits peptides dérivatisés, les phases Atlantis C18 et HALO C18 
permettent une très bonne résolution en HPLC, mais le système UPLC permet de réduire d’un 
facteur 2 { 3 le temps d’analyse pour une résolution identique. 
Mots-clés 
HPLC, UPLC, peptides, séparation. 
 
Ziel 
Verschiedene HPLC und UPLC Phasen wurden getestet hinsichtlich der Suche nach einem 
allgemeinen Ansatz für die Trennung von synthetischen Peptiden. 
Resultate 
Die Peptide von 20 Aminosäuren ± 2 Glyzinien, wurden die besten Trennung Ergebnisse mit der 
UPLC bei pH 3 mit einer Perchorat Lösung 100 mM erreicht, aber die HILC Phase kann mit einer 
etwas geringerer Trennleistung (Rs 1.06 gegen 1.60) die Analysedomen um den Faktor 1.5 
verkürzen. 
Die Diastereoisomere, kleine geschützte Peptiden, kann mittels Atlantis C18 und HALO C18 
Phasen ermöglichen eine sehr gute Auflösung in HPLC, aber das UPLC System reduziert um 
einen Faktor 2 bis 3 die Zeit Analyse für eine ziemliche identische Auflösung. 
Schlüsselwörter 
HPLC, UPLC, Peptiden, Trennung. 
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1. INTRODUCTION 
 
Today, the pharmaceutical industry is particularly interested in using rapid and efficient 
procedures for qualitative and quantitative analysis in order to cope with a large number of 
samples and to reduce the time required for delivery of results. The method of choice in 
pharmaceutical analysis for determining the concentration of drug substances in various 
matrices remains liquid chromatography coupled with different universal and/or selective 
detectors. 
However, conventional analysis times are usually longer than 10 min with columns of 15 cm 
length and 4.6 or 2.1mm internal diameter. In order to perform rapid or ultra-rapid procedures 
(i.e., cycle times lower than 5 or 1 min, respectively), different strategies can be applied [1]. 
 
The purpose of the current study purpose is to compare qualitatively different HPLC and UPLC 
columns for the separation of underivatized 20-mer peptides, deletions, hits and on derivatized 
diastereomers 4-mer peptides.  
 
Peptides are composed of chains of less than 50 amino acids and posses many different aspects. 
Thus, in addition to the highly variable polarity of these compounds, they may, in proportion to 
the length of the string, adopt secondary and tertiary structures that could influence retention 
on different HPLC supports [2]. 
The basic molecule of peptides is alanine (Figure 1) where R is a methyl group. R may take 20 
(Annex 1) different forms in “natural peptides” and many more in synthetic peptides. 
  Figure 1 
 
Amino acids are linked through a peptide bond (figure 2). The analyzed samples come from a 
production of the Lonza AG. The target compound consists of a 20 amino acid peptide ending 
with 4 glycines and the challenge is to show the influence of the different phases on the 
separation of this peptide and the different impurities that could appear in the synthesis of this 
peptide: “deletions and hits”, where hits are additions of one glycine and deletions are the same 
peptides with a glycine less. These deletions and hits appear during the synthesis of the peptide 
when for example a dimer in place of a monomer is attached to the growing chain (figure 6). 
  Figure 2 
 
Different HPLC columns are compared in order to find a good compromise between speed and 
quality of separation for analysis of impurities in the synthesis of a peptide. 
C
CH
NH
3
+
R
O
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Column types: 
 RP (C18 classical ; C18 wide pore) 
 UPLC (C18 sub 2 µm ; C18 sub 2 µm wide pore) 
 Monolithic column C18 
 PS-DVB (polystyrene divinylbenzene polymers) 
 HILIC (hydrophilic interaction liquid chromatography) 
 
HPLC RP phase 
RP HPLC is one of the most widely used techniques in the analysis of peptides. Indeed, in 
addition to its resolution ability, it allows the use of a wide variety of mobile phases, for example 
ACN and water mixed with TFA. The limit for the application of reverse phases is the time 
needed for analysis of polar molecules. Indeed, they cannot be separated as a result of weak 
interaction with the stationary phase [3]. 
 
       Figure 3 
Techniques like RP-HPLC with monolithic column and UPLC are rapid methods, an analysis time 
3 to 8 times faster than classical HPLC with 3 to 5 µm particles (figure 3) [1]. However, they are 
based on the same interactions as RP HPLC. The major difference is the change of structure of 
the phase: UPLC uses particles of less than 2 µm, as a result of wich the back pressure increases 
(Δ P: ≤ 700 bar) and the use of a specific HPLC system is required. The pore size ranges varies 
between 100 and 300 Å. 
The structure of a monolithic column illustrated in Figure 4 uses a polymerized silica C18 phase, 
with a two dimensional structure: macropores of 2 µm and mesopores of 130 Å. This structure 
allows the use of high flow rates while maintaining a reasonable back pressure. 
In fact, the loss of pressure is related to the diameter of the particles and the viscosity [4] as 
described by equation 1. 
∆P =
η∙L2∙u∙ϕ
dp
2 ∙t0
  Equation (1) 
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         Figure 4 
 
The study by Beth L. and al [a] of two identical reverse phase columns with different pore sizes 
(150 and 300 Å, Acquity, Waters, 2.1 x 100mm, 1.7 µm) on peptide mapping of 2 different 
proteins shows that with different porosity, different retention times are obtained for the same 
peptide. Retention times are not always correlated with the molecular weight, other phenomena 
are involved when the pores size is changed. 
 
HILIC phase 
Under the name HILIC is actually hidden a multitude of different phases. HILIC is the acronym of 
Hydrophilic Interaction LIquid Chromatography. This is a new name to describe a normal or 
reverse-reverse phase. Manufacturers sell under the name HILIC normal phase (silica) columns 
and phases grafted with polar groups such (PVA polyvinyl alcohol, primary amine propyl, 
diols,… cyano). This method offers an attractive alternative to the reverse phase for polar 
compounds because they often have short retention times in RP. Figure 5 illustrates the 
separation mode of a HILIC column. 
  Figure 5 
T. Yoshida [3] present a model (equation 3) based on equation 2 [4] which yields a linear 
relationship between the factor of retention and the proportion of solvent (in this case, water in 
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ACN). In the equations 2 and 3, k’ is the retention coefficient, k0 the coefficient of retention of 
water, S is the elution strength and ΦB the proportion of the polar solvent 
 
Log (k’) = Log (k0) – S (ΦB) Reverse phase   Equation (2). 
 
Log (k’) = Log (k0) – S Log (ΦB) normal phase   Equation (3). 
Other ways to separate complex mixtures involve a two-dimensional separation. For example, 
by combining a RP HPLC column and analyzing the fractions unseparated by RP with a second 
HILIC type column [3]. There is also the possibility of another way by separating first through a 
phase of SCX type, and then by carrying out a second separation by RP [5]. 
Derivatization 
The derivatization consists of adding a chromophore (fluorescamine, o-phthaldialdehyde for 
example) when UV-VIS detection is not sensitive enough or when the synthesis needs a 
protector group like the peptide synthesis. Figure 6 shows a widely used scheme of solid phase 
peptide synthesis; it is dominated by the use of BOC/benzyl and Fmoc/tert-butyl protection 
schemes. 
The derivatization can be done before or after the chromatographic separation.  
- Post derivatization: this allows for the separation of peptides in their native forms. 
- Ante derivatization: it allows a change the behavior of peptides for the chromatographic 
 separation.  
The chromophores are detected by LASER fluorescence (FLD). The derivatization thus improves 
the detection sensitivity by a factor 1000 compared with UV-VIS detection [2]. 
Derivatization also allows differentiating enantiomers. When an enantiomer mixture is 
derivatized with an enantiomericaly pure mixture one obtains two diastereomers. 
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         Figure 6 
1.1. ANALYSIS OF RESULTS AND COMPARISONS OF COLUMNS 
 
The criteria for comparing columns are: 
Reduced length: 𝑙 =
𝐿
𝑑𝑝
 Equation (4) 
Reduced plate height: ℎ =
𝐻
𝑑𝑝
=
𝐿
𝑁∙𝑑𝑝
  Equation (5) 
Reduced flow rate: 𝜐 =
𝑢∙𝑑𝑝
𝐷𝑚
=
𝑙∙𝑑𝑝
2
𝑡0∙𝐷𝑚
  Equation (6) 
These reduced characteristics allow adapting the methods to columns of various sizes while 
keeping the same resolution. Equation 7 and 8 allow adapting the flow rate according to the 
ratio of the diameters of two columns with equivalent lengths [2] and the injection volume. 
 
𝐹𝑙𝑜𝑤 𝑎 =  
𝑟𝑎
𝑟𝑏
 
2
∙ 𝐹𝑙𝑜𝑤 𝑏  Equation (7) 
Inj vol1= Inj vol2 (r2/r1)2 (L2/L1)  Equation (8) 
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The criteria for comparing the columns are first, the analysis time which is a decisive argument 
in industry and second, the resolution as expressed in equation 9 which is determinant for 
comparing the separation of two pairs of components [4]. 
𝑅𝑠 =
 𝑁
4
∙  
𝛼−1
𝛼
 ∙  
𝑘′
1+𝑘′
   Equation (9) 
Equation 9 involves the capacity factor of equation 13 as well as N, the number of theoretical 
plates (Equation 10) and the selectivity (Equation 11). H is the height of the peak, tr its retention 
time and A its area. There is another way to calculate N as shown above, like the moment 
method which consist of the surface of the peak calculated by integration of it, 5σ or half height 
method. 
𝑁 =
2𝜋∙ℎ2𝑡𝑟
2
𝐴2
  Equation (10) 
Or  
𝑁 =
µ1
2
µ2
 
Or 
𝑁 = 25  
𝑡𝑅
𝑊5𝜎
 
2
  𝑜𝑟  5.54 
𝑡𝑅
𝑊1/2
 
2
  
α, the selectivity is given by equation 11. 
𝛼 =
𝑘′2
𝑘′1
  Equation (11) 
k’, the capacity factor, is given by equation 12. 
𝑘′ =
𝑡𝑟−𝑡0
𝑡0
  Equation (12) 
 
Equation 13 calculates the plate height. This can be calculated with the help of the total length of 
the column L and the plate count N or with the Van Deemter equation. Where υ is the reduced 
flow rate, A is the Eddy diffusion, B is the longitudinal diffusion and C the mass transfer. 
𝐻 =
𝑁
𝐿
= 𝐴𝑢 +
𝐵
𝑢
+ 𝐶𝑢  Equation (13) 
The study of these different parameters allows through graphic representations such as H = f(u) 
and h = f(υ) to interpret the effects of various physical parameters such as pore diameter, 
particle size or separation of the considered peptides [1]. In order to take into account the 
viscosity of the eluent, according [6, 1] to the graphic representation (kinetic plots) with 
respectively separation impedance N2/tR = f(N) or retention impedance N2/tm = f(N) can be 
used to visualize the optimal plate count and time of analysis for one component. 
The impedance formula is given by equation 14. It allows taking into account of the viscosity of 
the eluent and the diffusion coefficient of the analyte. In this study, viscosity was measured, but 
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diffusion coefficient was calculated with a linear regression with an approximative mass of 
target peptide of 2600 kDa (20 AA at an average mass of 130 Da and two references 
ribonuclease (13700 kDa and 0.12X10-9 m2/s) and serum albumin (65000 kDa and 0.059X10-9 
m2/s) in water. This approximation gives a diffusion coefficient of 7.239X10-12 m2/s [7] 
𝐸 =  
𝑡𝑅 ∙∆𝑃
𝑁2∙𝜂∙(1+𝑘)
  Equation (14) 
E should, for a spherical particle optimally filled column, turn around 3000 and 5000 [4]. 
2. EXPERIMENTAL 
2.1. APPARATUS 
2.1.1. HPLC SYSTEMS 
 
Spectra-physics Analytical. 
  Degasser :  SCM 1000. 
  Pump :   P 4000. 
  Auto-sampler :  AS 3000. 
  Detector :  UV 2000. 
  Interface :   Agilent, 35900 E. 
  Program :  Chemstation for LC systems Agilent tech. 2001-2006 
     version Rev. B. 02. 01. [244]. 
  Dwell volume :  0.59 ml 
1100 series : 
  Degasser :  G1322A 
  Pump :   G1311A 
  Auto-sampler :  G1329A 
  Detector :  UV-VIS (DAD) G1315B 1024 array, cell : 13µl volume, 10 
     mm optic pathway. 
  Detector :  Fluorescence laser detector (FLD) G1321A array, cell : 8 µl 
     volume (0.5 X 80 mm). 
  Program :  Chemstation for LC systems Agilent tech. 2001-2006 
     version Rev. B. 02. 01. [244]. 
  Dwell volume :  0.94 ml 
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Waters Acquity UPLC system : 
  Lonza n°:  ZDUPLC314 
  Pump :   A05UPJ488M 
  Auto-sampler :  M04UPB5001M 
  Detector :  UV-VIS (WAJ081142) Waters, cell : 500 nl volume, 10 
     mm optical pathway 20 Hz sample rating. 
  Program :  Empower build 1154 copyright 2002. 
 
2.1.2. HPLC RP COLUMNS 
 
Table 1. Types of HPLC-RP columns. 
Manufacturer 
/ Name 
Part n°/lot 
Grafting 
 
Column 
sizes d x l 
[mm] 
Particle 
size 
[µm] 
 Pores 
size [Å] 
% 
carbon 
 Pore 
area 
m2/g 
Agilent / 
Zorbax 
863953-
902/B05103 
SB-C 18 4.6 x 150 3.5 80 12.5 180  
Waters / 
XBridge 
186003055/ 
010135237124 
10 
C 8 4.6 x 150 3.5 135 - - 
Waters / 
Atlantis 
186001317/ 
0114350261130
8 
dC 18 3.9 x 150 3.0 100 12 330  
Phenomenex 
/ Onyx 
CHO-7644/ 
050150-50 
Monolyt
ic C 18 
4.6 x 50 - 
Meso-
pores: 
130Å 
Macro-
pores: 
2µm 
- - 
Advanced 
material 
technology / 
Halo 
USGW001284 / 
AH72215 
C18 4.6 x 75 2.7 90 - - 
Waters / 
YMC 
BA99S051504FT 
/ 90306051 
Alkylsil
anes ≤ 
C8, 
neutral 
silica 
4.0 x 150 5 
Wide 
pore 
7 - 
Hamilton 79444 PS-DVB 4.1 x 150 5 100 - - 
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2.1.3. UPLC-RP COLUMNS 
 
Table 2. Types of UPLC columns. 
Manufacturer 
/ Name 
Part n°/lot 
Grafting 
 
Column 
sizes d x l 
[mm] 
Particle 
size 
[µm] 
 Pores 
size [Å] 
% 
carbon 
 Pore 
area 
m2/g 
Waters / 
Acquity 
30003 C18 2.1 x 150 1.7 130 17.41 183 
Waters / 
Acquity 
186003556 
C18 
special 
peptide  
2.1 x 150 1.7 130 17.93 197 
Waters / 
Acquity 
30049 C18 2.1 x 150 1.7 300 12.15 88 
 
2.1.4. HPLC-NP COLUMN 
 
Table 3. Types of HPLC-NP columns. 
Manufacturer 
/ Name 
Part n°/lot 
Grafting 
 
Column 
sizes d x l 
[mm] 
Particle size 
[µm] 
Pores size 
[Å] 
Waters / 
Atlantis 
186002019 / 
0102361813107 
Silice 3 x 100 3.0 - 
 
2.1.5. SAMPLES 
 
Table 4. Samples. 
Sample name Structure LIMS ID Remarques 
Problem 1: Double hits / 
Deletions       
Peptide_4G 
20mer with 4 consecutive 
Gly 39379 Target compound 
Peptide _3G 
 20mer with 3 consecutive 
Gly  67103   
Peptide_2G 
20mer with 2 consecutive 
Gly 4375142   
Peptide_5G 
20mer with 5 consecutive 
Gly 1414847   
Peptide_6G 
20mer with 6 consecutive 
Gly 44247   
Problem 2: diastereomers    
Pep-L-phe Fmoc-Cys(trt)-Gly-L-Phe V-1705-1  
Pep-L-phe Fmoc-Cys(trt)-Gly-D-Phe V-1707-1  
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2.1.6. LABORATORY SPECIFIC MATERIAL 
 
Analytical balances: 
   Mettler AE 240 
   Sartorius CP255D 
Viscosity measurements: 
   Capillary viscosimeter SCHOTT Geräte AVS 310. 
   Capillary Oc SCHOTT Geräte. 
   Water bath SCHOTT Geräte D 6238. 
PKa measurement: 
   Metrohm Dosimat 655. 
Turbidimetry measurement: 
   UV-VIS spectrophotometer libra S12 biochrom. 
   Plastibrand cuvettes N° 7590 15. 
 
2.1.7. REAGENTS 
 
Perchloric acid:  Fluka 77232 
Hydrochloric acid:  Fluka 84436 
Thiourea:   Fluka 88810 puriss. ≥ 99.0 % 
TFA:    Fluka 91707 puriss ≥ 99.0 % 
Sodiumperchlorate:  Fluka 71852 puriss ≥ 99.0 % 
Amonium formate:  Fluka 09739 puriss > 97 % 
Formic acid:   Fluka 06440 puriss > 98 % 
Sodium hydrogen sulfate: Fluka 71656 puriss > 93 % 
Ethanol:   Fluka 02860 puriss ≥ 99.8 % 
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2.1.8. ELUENTS 
 
H2O Milli-Q Millipore Q-Gard 2 
Perchlorate solution 100 mM pH 3.0 
Acetate Buffer 10 mM pH 4 
Phosphate buffer 10 mM pH 2 and 3 
Formate buffer 10 mM pH 2 
ACN Lab-Scan for HPLC C17C11X 
Methanol for HPLC Merck 1.06018.2500  
Ethanol  
2.2. METHODS 
 
2.2.1. VISCOSITY MEASUREMENTS 
 
The viscosity measurements of eluents were conducted with the intention to characterize 
columns in order to calculate the impedance during isocratic test mode. First, the density was 
determined by weighing three times a sample of 5 ml of the mixture 75/25 ACN / phosphate 
buffer 10 mM pH 2 and 3 for HILIC and 25/75 ACN / phosphate buffer 10 mM pH 2 and 3 for RP-
HPLC. After 5 minutes of acclimatization at 25 °C, the viscosity (transit time) was measured 3 
times with samples of about 20 ml in the capillary viscosimeter. 
2.2.2. TURBIDIMETRY MEASUREMENTS 
 
2 ml samples of mixtures 95/5 ACN / phosphate buffer (100 mM and 10 mM) pH 2 and mixtures 
85/15 ACN / phosphate buffer (100 mM and 10 mM) pH 2 were measured twice at 750 nm to 
determine if there was formation of a precipitate. Zero was fixed through water. 
2.2.3. DWELL TIME 
 
Dwell time was measured twice on both systems, spectra physics and Agilent 1100, with a 
solution of toluene 5.6 mg/l in water at a flow rate of 0.2 ml/min detection at 215 nm. For the 
spectra physical system the measurement was made at 2.2 ml/min. 
2.2.4. PKA DETERMINATION 
 
pKa determination of the target compound was carried out with 1 ml of a solution 2.57 g/l in 
water of the peptide 4gly with an addition of 2 ml of NaOH 0.1 mol/l. 
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2.2.5. KINETIC AND KNOX PLOTS 
 
For HILIC: a sample of target compound (4gly) of 2.03 mg was dissolved in 110 µl formic acid 
and 890 µl ACN [3] and analyzed with a dilution factor of 2. The dead time of the column was 
measured with a solution of 56 mg/l of toluene. The blank was composed of 110 µl formic acid 
and 890 µl ACN. The flow rates were varied from 0.1 ml/min to 1.6 ml/min. 10 µl were injected 
and the run isocratically with 75 / 25 ACN / buffer. Detection was at 215 nm.  
For RP-HPLC: a sample of the target compound (4gly) of 10.51 mg and 8.36 mg of thiourea (dead 
time) were dissolved in 5ml with in water and diluted by a factor 20 the blank is composed of 
water. Flow rates were varied between 0.1 ml/min to 1.5 ml/min. and between 1.0 to 5 ml/min 
for ONYX monolithic column. Analyses were run in isocratic mode with 25 / 75 ACN / buffer. 
Detection was at 215 nm. 
Measures were made with Agilent 1100 HPLC at 25°C and sample rate was 1 point per second. 
Integration parameters were: slope sensitivity 5, peak width 0.05, area reject 5 height reject 1. N 
was calculated by chemstation by the half height of the peak method. 
2.2.6. DIASTEREOMERES ANALYSIS 
 
For HPLC analysis, samples were dissolved in ethanol solution of peptide L-phe (1.053 mg/ml) 
and peptide D-phe (1.203 mg/ml) were prepared. A spiking 1:1 of both diastereomers was also 
prepared. These samples were injected (5 µl) on Waters Atlantic C18 with a gradient from 50 / 
50 to 10 / 90 buffers pH 2, 3, 4, 5 / ACN in 30 minutes at 40 °C with a flow rate of 0.8 ml/min . 
The blank was ethanol and dead time was measured with a solution (0.0107 mg/ml) of thiourea 
in methanol. Acquisition was made with Spectra physics HPLC system and parameters were: rise 
time : 3.0, and range one and two at 1.0 detection was carried out at 215 nm. N was calculated by 
chemstation with the half height of the peak method. . 
For UPLC analysis, samples were dissolved in ethanol solution of peptide L-phe (1.053 mg/ml) 
and peptide D-phe (1.203 mg/ml) were prepared. A spiking 1:1 of both diastereomers was also 
prepared. These samples were injected (2 µl) on a gradient from 40 /60 to 10 /90 acetate buffer 
at pH 4 / ACN in 17.20 minutes at 40 °C and 60 °C with a flow rate of 0.4 ml/min. The blank was 
ethanol and dead time was measured with a solution (0.0107 mg/ml) of thiourea in methanol. 
Acquisition was made with Waters Acquity UPLC system and parameters were: 20 points per 
sec., filter time constant, 0.5 sec., detection was carried out at 215 nm. N was calculated by 
EMpower with the 5σ method. 
 
2.2.7. NOTE 
 
All chromatograms and calculation that are not presented in the results section, are available in 
the annex 1, 2, 3, 4, 5 at laboratory F103 at HES-SO, route du Rawyl 64, CH-1950 Sion. 
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3. RESULTS AND DISCUSSION 
 
3.1. CHARACTERIZATION OF THE PEPTIDE  
3.1.1. PKA MEASURES OF PEPTIDE 4GLY : 
 
The pKa of peptide was measured to determine the pH range in which target peptide (4 gly), is in 
a stable form. For this purpose, a reverse titration was carried out.  
 
 Figure 7: Analyses n°1 of the titration of peptide 4 gly with HCl 0.1 M 
 
Figure 7 shows that between pH 2 and 3 the peptide is in a stable protonated form. Table 5 
shows the average of the two analyses. The pKa 2 at 4.65 involves that part of the peptide is in an 
unprotonated form. Chromatographic analyses should therfore be carried out below pH 3 or 
above pH 10.5 for more reproducible time of retention and peak sharpness. But few silica based 
phases are capable to resist above pH 8 because of hydrolysis. Therefore PH 2 and 3 were 
retained to carry out the analysis.  
 Table 5. Average of pKa analyses 1 and 2. 
  pKa 1 pKa 2 
Analyse 1 7.82 4.53 
Analyse 2 7.65 4.78 
Average 7.74 4.65 
SD 0.12 0.18 
CV 1.52 3.81 
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3.2. CHARACTERIZATION OF THE MEASUREMENT SYSTEM  
 
3.2.1. TURBIDIMETRY MEASUREMENTS: 
 
Turbidimetry measurements were made because phosphate buffer (10 mM) was chosen to carry 
out measurements and at a high concentration of ACN phosphate salt precipitates. Phosphate 
buffer facilitates the measurements because of its UV transparency, compared to formate acetate 
or glycine buffers. Results of analyses of mixtures of 95/5 and 85/15 ACN phosphate buffer 100 
and 10 mM are shown in table 6. 
 
 Table 6. Turbidimetry analyses of different eluent solutions. 
 Absorbance at 750mn [-] 
Solutions Analyse 1  Analyse 2 
95/5 ACN / water 0.086 0.086 
95/5 ACN / 100 mM buffer 0.200 0.230 
95/5 ACN / 10 mM buffer 0.086 0.083 
85/15 ACN / water 0.062 0.063 
85/15 ACN / 100 mM buffer 0.291 0.272 
85/15 ACN / 10 mM buffer 0.062 0.065 
 
Table 5 shows clearly that at concentrations of 10 mM there is no precipitation the values are 
under the limit of detection. By contrast, at high concentrations it is possible to observe a 
precipitate. 
 
3.2.2. VISCOSITY MEASUREMENTS: 
 
Viscosity measurements were carried out to determine the impedance that reflects the quality of 
the filling of the column. For HILIC and RP columns, results are summarized in table 7. The high 
content of volatile ACN can explain the small difference between the HILIC and RP-HPLC 
standard deviation. A complete table of results is presented in annex 6 and 7. 
 Table 7. Viscosity analyses of different eluent mixtures. 
 Type of eluent pH η [Pa*s] Standard deviation 
HILIC 
75/25 ACN / phosphate 
buffer (10 mM)  
2 4.90 X10-4 1 X10-6 
75/25 ACN / phosphate 
buffer (10 mM)  
3 5.12 X10-4 6 X10-6 
RP-HPLC 
25/75 ACN / phosphate 
buffer (10 mM)  
2 9.05 X10-4 4 X10-6 
25/75 ACN / phosphate 
buffer (10 mM)  
3 9.04 X10-4 3 X10-6 
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3.3. CHARACTERIZATION OF THE HPLC PHASES 
 
To characterize the different phases, the kinetic plot method [6] was chosen for its abilities to 
show at the same time the optimum plate count and the optimal time for the analysis and for the 
different possibilities to present it graphically. 
3.3.1. VAN DEEMTER CURVES AND KINETIC PLOTS 
 
First the reduced value plots, figure 8 and 9, show that the best reduced plate height is obtained 
with the HILIC phase for a reduced flow rates of over 900. It represents a flow rate of 0.9 
ml/min. For these specific plots, the diffusion coefficient used for the calculation of reduced flow 
rate is 7.239X10-12 [m2/s] as calculated in the introduction. All chromatogram and tables of 
results are presented in annex 1. 
 
 
 Figure 8. Reduced plate height in function of the reduced flow rate at pH 2. 
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 Figure 9. Reduced plate height in function of the reduced flow rate at pH 3. 
Hamilton PRP-1 phase does not appear on figure 9 because the tailing effect was so strong that it 
was not representative enough to be shown graphically. 
It is important to note that ONYX monolithic column does not figure in these figures as its 
internal structure is made of polymerized silica, without particles. 
For this reason a second plot method was chosen to represent the optimal phase for peptide 
4gly separation. 
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Figure 10. Separation impedance of peptide 4 gly at pH 3 for the different phases. 
 
Figure 11. Separation impedance of peptide 4 gly at pH 2 for the different phases. 
 
Figure 10 and 11 show the retention impedance of the different phases at pH 2 and 3 [9]. The 
minima of the curves indicate the obtained optimal plate count. From left to right the shift of the 
optimum shows a shorter analysis time and a lower plate count.  
Two columns stand out from the lot at pH 2. Waters Atlantis C18 and Atlantis HILIC give the best 
plate count. The fastest column is the ONYX monolithic column but it has the inconvenience of 
having a lower plate count than the two others and significant eluent consumption due to fast 
flow rate. The Atlantis C18 gives the longest tm for the best plate count. And in the middle there 
is the HILIC phase with a slightly shorter tm and lower plate count. 
At pH 3 there is no compromise, the best plate count is obtained with the Waters Atlantis HILIC 
phase. This is due to a tailing effect apparently induced by the use of phosphate buffer and 
reverse phases.  
3.3.2. TESTS WITH HILIC AND GRADIENT ELUTION 
 
The results obtained with kinetic plot method were confirmed with gradient tests. Figure 12 and 
13 show results obtained with Waters Atlantis HILIC and a gradient elution from 85/15 to 
65/35 ACN / 10 mM phosphate buffer pH 2 and 3 in 20 minutes with a flow rate of 1.0 ml/min. A 
sample of a mix of each peptide was injected. All chromatogram and tables of results are 
presented in annex 2. 
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Figure 12. Chromatogram of a spiking with peptide 2, 3, 4, 5, 6 gly with HILIC phase at pH 2, 
 second injection. 
 
Figure 13. Chromatogram of a spiking with peptide 2, 3, 4, 5, 6 gly with HILIC phase at pH 3 
 second injection. 
These results confirm the kinetic plot method and show that at pH 3 the retention time obtained 
are slightly longer than at pH 2. But the average resolution is the same, 1.06, for the two 
different pH. 
3.3.3. TESTS WITH RP-HPLC AND GRADIENT ELUTION 
 
The chromatograms obtained with columns ONYX and Atlantis C18 are presented in figure 14 
and 15. The gradient elution details are presented in annex 2 and consist of a step gradient 
elution from 20/80 to 95/5 ACN / 10 mM phosphate buffer pH 2. This gradient is an adaptation 
of the gradient used by Lonza A.G. with the UPLC system (annex 3) and was adapted to the HPLC 
system with. A mix of a spiking of each peptide was injected.  
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Figure 14. Chromatogram of a spiking of peptide 2, 3, 4, 5, 6 gly with Atlantis C18 phase at pH 
  2 second injection. 
 
Figure 15. Chromatogram of a spiking of peptide 2, 3, 4, 5, 6 gly with ONYX monolithic C18  
 phase at pH 2 second injection. 
Two problems were encountered; the first one was the poor resolution, insufficient to resolve 
the 5 different peptides and the relatively poor sharpness of the peak.  
These problems were partially resolved for the Atlantis C18 phase with the replacement of the 
phosphate buffer by the perchlorate solution at pH 3 with the same elution gradient. 
 
Figure 16. Chromatogram of a spiking of peptide 2, 3, 4, 5, 6 gly with Atlantis C18 phase with 
 perchlorate solution pH 3. 
Average resolution obtained for the separation increases from 1.6 to 2.5. This is an interesting 
result for the adaptation of an optimized gradient in UPLC on an HPLC system. The only 
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disadvantage is that the separation occurs in about 32 minutes with a 60 minute gradient. As 
shown in the kinetic plot, the Atlantis gives a better plate count as the HILIC phase but with a 
longer analysis time. Moreover with perchlorate solution, batch to batch retention time 
reproduction is not assured.  
Other phases were tested with gradient elution, Waters YMC C8 wide pore, Halo C18 and Waters 
Xbridge C8. Results were disappointing, even with buffered eluent, retention time was not 
reproducible as expected and tailing effect was strong. These analyses are presented in annex 2 
One problem has to be highlighted. The one by one injection of the different peptides shows that 
peptide 4 gly and 5 gly were irresolvable; they have the same retention time. This problem has 
been solved by replacing the original batch of peptide 5 gly by a new one. The results obtained 
with the HILIC phase in figure 12 and 13 shows the 5 peptides resolved. 
 
3.4. CHARACTERIZATION OF THE UPLC PHASES 
 
To characterize the different UPLC phases another approach was chosen as the phases differ 
only in pore size, the same method (annex 3) was used to observe the differences in retention 
time and resolution between the columns. The method consist of a step gradient elution from 
20/80 to 95/5 ACN / 100 mM perchlorate solution at pH 3 with a flow rate of 0.25 ml/min. The 
next four figures (17 to 20) present the second injection on the three different columns BEH C18, 
BEH130 and BEH300. It is important to note that BEH 130 is sold in the commerce as a special 
column for peptide separation but it has the same specification as the BEH C18 column. The only 
changes are in carbon % and pore area that are slightly important for BEH 130 phase. 
 
 
Figure 17. Chromatogram of a spiking of peptide 2, 3, 4, 5, 6 gly with Waters BEH C18 phase 
 with perchlorate solution at pH 3 First injection. 
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Figure 18. Chromatogram of a spiking of peptide 2, 3, 4, 5, 6 gly with Waters BEH C18 phase 
 with perchlorate solution at pH 3 second injection. 
 
Figure 19. Chromatogram of a spiking of peptide 2, 3, 4, 5, 6 gly with Waters BEH 130 C18  phase 
with perchlorate solution at pH 3 second injection. 
 
 
Figure 20. Chromatogram of a spiking of peptide 2, 3, 4, 5, 6 gly with Waters BEH300 C18  phase 
with perchlorate solution at pH 3 second injection. 
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 Table 8. Values obtained for resolution with 
 the three different phases and perchlorate solution. 
Peaks BEH C18 BEH 130 C18 BEH 300 C18  
6 gly 1.77 1.85 1.79 
5 gly 1.82 1.91 1.86 
4 gly 2.06 2.07 2.07 
3 gly 2.37 2.38 2.40 
2 gly 1.39 1.74 3.36 
 
The resolution obtained (table 8) for the three different columns shows no significant 
differences. The only difference noted was in the results obtained with the BEH 130 column but 
this column was a brand new phase lent by waters especially for this study that also could 
explain the differences between the retention times. The different values of Rs (resolution) were 
calculated with the average plate counts as shown in annex 3  
In order to try to suppress the variability of the retention times caused by unbuffered 
perchlorate solution, tests were made with formate buffer at pH 2. The figures below show the 
different analyses carried out with formate buffer with the same gradient as with perchlorate 
solution (annex 7). We can see a better reproducibility between retention times is observed but 
no correlation between retention time and pore size for example. By contrast it is interesting to 
note that BEH 130 and 300 induce a strong tailing effect. In addition, BEH 130 and BEH C18 have 
the same properties. It is to notice that due to the use of formic acid, the response of the system 
is reduced by a factor of 40. The detection was performed at 260 nm. 
 
Figure 21. Chromatogram of a spiking of peptide 2, 3, 4, 5, 6 gly with Waters BEH C18 phase 
 with formate buffer at pH 2 first injection. 
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Figure 22. Chromatogram of a spiking of peptide 2, 3, 4, 5, 6 gly with Waters BEH C18 phase 
 with formate buffer at pH 2 second injection. 
 
 
Figure 23. Chromatogram of a spiking of peptide 2, 3, 4, 5, 6 gly with Waters BEH130 C18 p
 hase with formate buffer at pH 2 second injection. 
 
 
Figure 24. Chromatogram of a spiking of peptide 2, 3, 4, 5, 6 gly with Waters BEH300 C18  phase 
with formate buffer at pH 2 second injection. 
 
 
HPLC optimization  Gaudard Olivier 
  29  
 
 Table 9. Values obtained for resolution with 
 The BEH C18 phases and formate buffer pH 2 solution. 
Peaks BEH C18  
6 gly 1.291 
 
5 gly 1.088 
 
4 gly 1.743 
 
3 gly 1.995 
 
 
Resolution obtained with formate buffer pH 2 is slightly lower than with perchlorate solution pH 
3 but with an adaptation of the gradient this could be improved. The only shadow of this system 
is the low response due to formate’s strong absorbance in UV domain. Moreover the tailing effect 
for BEH 130 and 300. 
To summarize this part, first, the kinetic plot method is a powerful tool to find optimal 
conditions for the use of the phases. It gives fine tendencies to guide through the choices of an 
incredible number of available phases. The main disadvantage is that it that it takes long time to 
precede to the test of the columns. The second disadvantage is that it works for the compound 
tested in the condition tested and not for other compounds as seen in the second problem for 
the separation of smaller protected peptides. 
With an increase of 4 to 10 times more plate count, UPLC is for the moment the quickest way to 
analyze these middles sized peptides with the best resolution.  
3.5. HPLC AND DIASTEREOMER PROBLEM  
 
The first problem encountered with the diastereomers was the relatively poor solubility of these 
compounds in water and ACN (certainly due to the apolar protector groups trt and fmoc). Tests 
were made to find the right solvent. These were methanol, ethanol and dimethylformamide. 
Ethanol was chosen for these analyses.  
The first optimized parameter was pH through a test with Atlantis C18 column with a classical 
50 / 50 to 95 / 5 ACN / buffers pH 2, 3, 4 and 5 in 30 minutes with a flow rate of 0.8 ml/min. As 
shown in figure 25, optimal phase separation is obtained at pH 4 with a resolution of 1.4. The 
details of the methods used are presented in annex 4. 
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 Figure 25. Resolution in function of different pH values. 
Figures 26 to 28 show the effect of the different HPLC phases on diastereomer separation. 
 
 
Figure 26. Chromatogram of a spiking of peptide L-phe and D-phe with Waters Atlantis C18 
 phase with acetate buffer at pH 4 second injection. 
 
Figure 27. Chromatogram of a spiking of peptide L-phe and D-phe with HALO C18 phase with 
 Acetate buffer at pH 4 second injection. 
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Figure 28. Chromatogram of a spiking of peptide L-phe and D-phe with YMC C8 phase with 
 Acetate buffer at pH 4 first injection. 
The resolution obtained with Waters Atlantis phase at pH 4 is 1.43. HALO phase resolution is 
better with 1.68. The smaller particle size could explain this gain in resolution even if HALO is 75 
mm shorter than the Waters Atlantis column.  
YMC phase seems to be inappropriated for this separation. It is certainly due to its larger 
particles, its C8 grafting and its pore size. Moreover a tailing effect appears with this column. 
 
3.6. UPLC AND DIASTEREOMER PROBLEM  
 
The gradient used for analysis was calculated by Veuthey’s calculator tool (Lonza software) in 
order to adapt the HPLC gradient and the injection load to UPLC system. The method consist of a 
step gradient elution from 60/40 to 90/10 ACN / 10 mM acetate buffer at pH 4 in 17 .2 minutes 
with a flow rate of 0.40 ml/min 
First tests were made at 60 °C at pH 4 and another series of assays were carried out at 40 °C to 
check the effect of temperature on the separation of the diastereomer. The only series presented 
is the one carried out at 40 °C the other one is in presented in annex 5. 
Figures 29 to 31 show the effect of the different UPLC phases on diastereomers separation. 
 
Figure 29. Chromatogram of a spiking of peptide L-phe and D-phe with BEH C18 phase with 
 Acetate buffer at pH 4 second injection 40 °C. 
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Figure 31. Chromatogram of a spiking of peptide L-phe and D-phe with BEH130 phase with 
 Acetate buffer at pH 4 second injection 40 °C. 
 
Figure 31. Chromatogram of a spiking of peptide L-phe and D-phe with BEH300 phase with 
 Acetate buffer at pH 4 second injection 40 °C. 
 Table 10. Values obtained for resolution with 
 UPLC phases at different temperatures. 
  Resolution 
Column 40 °C 60 °C 
BEH C18 1.49 1.28 
BEH 130 1.37 1.10 
BEH 300 1.30 0.97 
 
Table 10 shows that the resolution increases at the lower temperature and with a reduction of 
the pore size.  
The resolution obtained (table 10) for the three different columns show slight differences. The 
BEH 130 especially designed for peptide separation has a significantly poorer resolution than 
the BEH C18 “standard”. Moreover, if pore size has a slight effect on resolution, a temperature 
increase has a strong negative effect on the diastereomer separation. The different tables of 
results and calculation are presented in annex 5. 
To summarize, with an analysis 2 times faster, UPLC is for the moment the quickest way to 
separate these small size diastereomer peptides. HPLC methods with the HALO phase is a good 
compromise between time analysis and resolution. Thus, it would be useful to test, a 150 mm 
HALO phase. 
HPLC optimization  Gaudard Olivier 
  33  
 
4. CONCLUSION AND PERSPECTIVES 
 
The Kinetic plot method is powerful method for the characterization of very different phases like 
in the first problem with the middle size peptide. It is perhaps not the fastest method for the 
phases analysis, moreover its results are valuable only for the conditions tested. Indeed, when 
phosphate was changed to perclorate solution as done with Waters Atlantis C18, an increase of 
resolution was observed. But the results obtained with this method allow to get an overview of 
the optimal phases to proceed to the separation. The second disadvantage is that it works for the 
compound tested and not for other compounds as seen in the second problem for the separation 
of smaller protected peptides. 
For the separation of the medium size peptide, UPLC is for the moment the method that gives the 
best resolution. There may be a solution to be tested with the use of an HLIC phase especially 
made for UPLC it may be a reasonable way to enhance time analysis. Otherwise no significant 
differences were found between the three UPLC columns.  
For the small peptides diastereomers problem, the differences between the phases are more 
visible. First the particle size seems to influence more the separation than for the first problem. 
This is certainly due to the more apolar character of this compound. Here, smaller particle size, 
smaller pore size and a temperature not over 40 °C seem to enhance the separation of the 
diastereomers. A way to improve separation could be the use of a HALO phase of 150 mm length 
in place of the 75 mm one tested. 
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5. NOMENCLATURE 
 
HILIC :  Hydrophilic interaction liquid chromatography. 
HPLC RP : High performance liquid chromatography reverse phase. 
HPLC NP : High performance liquid chromatography normal phase. 
Peptide : chain of more no more than 50 amino acids [4]. 
UPLC :  Ultra performance liquid chromatography. 
SCX :  Strong Cation Exchange. 
ACN :  Acetonitrile. 
TFA :  Trifluoroacetic acid. 
MeOH :  Methanol. 
FLD :  Fluorescence Laser Detector.  
A :  Knox term for Eddy diffusion 
B :  Knox term for longitudinal diffusion 
C :  Knox term for mass transfer resistance 
dp :  particle size in packed bed 
DmA,B :  diffusion coefficient of solute A at very low concentration 
  in solvent B 
E :  separation impedance 
h :  reduced height equivalent of a theoretical plate 
hopt :  optimal reduced height equivalent of a theoretical plate 
H:  height equivalent of a theoretical plate 
Hopt :  optimal plate height leading to highest efficiency 
K :  retention factor of a compound 
Kv :  column permeability based on interstitial velocity 
L :  column length 
N :  plate number or plate count 
tr :  retention time of a compound 
tm :  dead time 
η :  dynamic mobile phase viscosity 
trt :  triphenylethyl aminoacid side chain protector group.  
Fmoc :  (F)luorenyl-(m)eth(o)xy-(c)arbonyl 
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8. ANNEXES 
 
Annex 1  [8] 
Annex 2  [9] 
Annex 3  [10] 
Annex 4  [11] 
Annex 5  [12] 
Annex 6  Tables of viscosity measurements for HILIC at pH 2 and 3 
Annex 7  Tables of viscosity measurements for RP-HPLC at pH 2 and 3. 
Annex 8  Tableau comparatif des différents types de phases de leurs avantages et de leurs 
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Annex 6. Tables of viscosity measurements for HILIC at pH 2 and 3 
       75 / 25 ACN Tampon phosphate 10 mM pH 2 
      ρ [Kg/m3] Temps de passage [s] Constante K Correction de Hagenbach Viscosité cinétique [mm2/s] Viscosité dynamique [Pa*s] 
essai 1 851 194.18 0.003 1.77 0.57723 4.91E-04 
essai2 848 194.34 0.003 1.77 0.57771 4.90E-04 
essai 3 846 194.27 0.003 1.77 0.5775 4.89E-04 
moyenne            4.90E-04 
ecart type           1E-06 
       
       75 / 25 ACN Tampon phosphate 10 mM pH 3 
      ρ [Kg/m3] Temps de passage [s] Constante K Correction de Hagenbach Viscosité cinétique [mm2/s] Viscosité dynamique [Pa*s] 
essai 1 871 199.31 0.003 1.77 0.59262 5.16E-04 
essai2 857 199.26 0.003 1.77 0.59247 5.08E-04 
moyenne            5.12E-04 
ecart type           6E-06 
        
 
 
 
 
 
 
    
Annex 7. Tables of viscosity measurements for RP-HPLC at pH 2 and 3. 
       75 / 25 ACN Tampon phosphate 10 mM pH 2 
      ρ [Kg/m3] Temps de passage [s] Constante K Correction de Hagenbach Viscosité cinétique [mm2/s] Viscosité dynamique [Pa*s] 
essai 1 956 317.34 0.003 0.725 0.949845 9.079E-04 
essai2 949 317.32 0.003 0.725 0.949785 9.015E-04 
moyenne            9.05E-04 
ecart type           4E-06 
       
       75 / 25 ACN Tampon phosphate 10 mM pH 3 
      ρ [Kg/m3] Temps de passage [s] Constante K Correction de Hagenbach Viscosité cinétique [mm2/s] Viscosité dynamique [Pa*s] 
essai 1 946 317.87 0.003 0.725 0.951435 9.00E-04 
essai2 951 317.88 0.003 0.725 0.951465 9.05E-04 
essai 3 952 317.91 0.003 0.725 0.951555 9.06E-04 
moyenne            9.04E-04 
ecart type           3E-06 
        
 
 
    
 
ANNEXE 8. TABLEAU COMPARATIF DES DIFFÉRENTS TYPES DE PHASES, DE LEURS AVANTAGES ET DE LEURS INCONVÉNIENTS [1]. 
Type de colonne 
Type de 
greffage 
Avantages Inconvénients 
Domaine d’utilisation / 
Fabricant et nom 
Monolithiques C8, C18, Si 
Faible perte 
de charge 
Différents 
types de 
squelettes 
disponibles 
Technique 
récente, 
Faible 
résistance de 
la colonne. 
Stabilité de la 
phase 
stationnaire 
pH : 2-7.5 
ΔP : ≤200 bar 
T : ≤ 35° C 
Surface spécifique: 300 
m2/g  
Taille des pores: 
- Mesopores: 130Å 
- Macropores: 2µm  
Volume des pores: 1 mL/g 
Porosité: > 80%  
[b] / 
Phenomenex, Onyx 
HPLC 
HILIC [3] 
 
Permet de 
retenir les 
acides aminés 
polaires 
Temps 
d’analyse 
pH : 1-5 
ΔP : ≤400 bar 
T : 20 à 40° C 
Taille des particules: 3 µm 
[c] 
HPLC 
C 18 et C 18 
wide pore 
Méthode 
éprouvée et 
largement 
utilisée 
 
Rapidité 
Difficulté de 
séparation 
des peptides 
polaires 
 
pH : 2-7 
ΔP : ≤ 400  bar 
T : 20-40 °C 
Taille des pores: 
100 Å 
300 Å (wid pore) 
Taille des particules: 3 µm 
[c] 
PS-DVB -  
Grande 
résistance au 
pH 
Temps de 
rétention des 
composés 
polaires 
pH : 1 à 13 
ΔP : ≤ 400 bar 
T : 5-60 °C 
Taille des pores: 
100 Å 
Taille des particules: 5 µm 
[d] 
 
UPLC 
C8, C18, shield 
RP18, HILIC, 
phényl, sub 2 
µm 
C18 sub 2 µm 
wide pore 
 
Possibilité de 
réduire 
considérable
ment le temps 
d’analyse 
 
Appareillage 
spécifique 
ΔP~1000 bar 
Peu de phases 
stationnaires 
stables 
disponibles 
Compressibili
té des 
solvants 
 
pH : 1-12 (dépend du 
gréphage) 
ΔP : ≤ 700 bar 
T : ≤ 70 C 
Taille des pores: 
130 Å 
300 Å (wid pore) 
Surface spécifique: 180 m/g  
Volume des pores: 0.7 mL/g 
Taille des particules: 1.7 µm 
[e]  
Waters, acquity 
 
